z-logo
open-access-imgOpen Access
Letter by Govindarajan and Salgado Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial”
Author(s) -
Raghav Govindarajan,
Efrain Salgado
Publication year - 2012
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.053710
Subject(s) - medicine , warfarin , dabigatran , atrial fibrillation , aspirin , clopidogrel , randomized controlled trial , subgroup analysis , anticoagulant , cardiology , surgery , confidence interval

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom